{"id":"https://openalex.org/W4659586","doi":null,"title":"Serum sickness-like reaction to cefuroxime: a case report and review of the literature.","display_name":"Serum sickness-like reaction to cefuroxime: a case report and review of the literature.","alternate_titles":[],"publication_year":2007,"publication_date":"2007-07-01","ids":{"openalex":"https://openalex.org/W4659586","mag":"4659586","pmid":"https://pubmed.ncbi.nlm.nih.gov/17763603"},"language":"en","primary_location":{"id":"pmid:17763603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17763603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Case Reports"},"parent_works":[],"lineage":["https://openalex.org/W4659586"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018754435","display_name":"Rajani Katta","orcid":"https://orcid.org/0000-0002-3396-7643","observed_orcids":["https://orcid.org/0000-0002-3396-7643"]},"institutions":[{"id":"https://openalex.org/I181547552","display_name":"Baylor College of Medicine","ror":"https://ror.org/02pttbw34","country_code":"US","type":"education","lineage":["https://openalex.org/I181547552","https://openalex.org/I2801539370"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rajani Katta","raw_affiliation_strings":["Department of Dermatology, Baylor College of Medicine, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Baylor College of Medicine, Houston, TX, USA","institution_ids":["https://openalex.org/I181547552"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5084299297","display_name":"Vijayalaxmi Anusuri","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vijayalaxmi Anusuri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.8548,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.73216642,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"6","issue":"7","first_page":"747","last_page":"748"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.007199999876320362,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11153","display_name":"Streptococcal Infections and Treatments","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serum-sickness-like-reaction","display_name":"serum sickness-like reaction","score":0.996999979019165},{"id":"https://openalex.org/keywords/cefuroxime","display_name":"cefuroxime","score":0.9990000128746033},{"id":"https://openalex.org/keywords/cephalosporin-hypersensitivity","display_name":"cephalosporin hypersensitivity","score":0.8289999961853027},{"id":"https://openalex.org/keywords/mastitis","display_name":"mastitis","score":0.7670000195503235},{"id":"https://openalex.org/keywords/drug-induced-rash","display_name":"drug rash","score":0.4959999918937683},{"id":"https://openalex.org/keywords/systemic-corticosteroid-therapy","display_name":"systemic corticosteroid therapy","score":0.847000002861023},{"id":"https://openalex.org/keywords/second-generation-cephalosporins","display_name":"second-generation cephalosporins","score":0.8880000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9561140537261963},{"id":"https://openalex.org/C64778159","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin","level":3,"score":0.8959978222846985},{"id":"https://openalex.org/C2777514703","wikidata":"https://www.wikidata.org/wiki/Q413728","display_name":"Cefuroxime","level":3,"score":0.8843357563018799},{"id":"https://openalex.org/C2779766023","wikidata":"https://www.wikidata.org/wiki/Q415167","display_name":"Cefaclor","level":4,"score":0.8142082691192627},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7276657819747925},{"id":"https://openalex.org/C2910308651","wikidata":"https://www.wikidata.org/wiki/Q271021","display_name":"Cephalosporin Antibiotic","level":4,"score":0.5887547731399536},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5392851233482361},{"id":"https://openalex.org/C2779703309","wikidata":"https://www.wikidata.org/wiki/Q33121","display_name":"Serum sickness","level":3,"score":0.4543449580669403},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.35348665714263916},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.32769036293029785},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.32101520895957947},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.32097822427749634},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1736140251159668},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.0},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000900","descriptor_name":"Anti-Bacterial Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002444","descriptor_name":"Cefuroxime","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D002444","descriptor_name":"Cefuroxime","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008413","descriptor_name":"Mastitis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D012713","descriptor_name":"Serum Sickness","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D012713","descriptor_name":"Serum Sickness","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018771","descriptor_name":"Arthralgia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17763603","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17763603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Case Reports"},{"id":"mag:4659586","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17763603","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/case-report","display_name":"Case Report"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W2287643117","https://openalex.org/W54372785","https://openalex.org/W2417036052","https://openalex.org/W2099429823","https://openalex.org/W1970649702","https://openalex.org/W2062873692","https://openalex.org/W2034588788"],"related_works":["https://openalex.org/W2411237928","https://openalex.org/W2765874044","https://openalex.org/W1846934027","https://openalex.org/W4300922776","https://openalex.org/W2057649656","https://openalex.org/W2435232930","https://openalex.org/W75677387","https://openalex.org/W63885274","https://openalex.org/W7206661572","https://openalex.org/W1999934421"],"abstract_inverted_index":{"We":[0],"report":[1],"a":[2,5,11,21,27,47,53],"case":[3],"of":[4,55,57],"34-year-old":[6],"woman":[7],"who":[8],"received":[9],"cefuroxime,":[10],"second-generation":[12,48],"cephalosporin,":[13],"as":[14,63],"treatment":[15,38],"for":[16],"mastitis.":[17],"She":[18,35],"subsequently":[19],"developed":[20],"serum":[22],"sickness-like":[23],"reaction":[24],"(SSLR)":[25],"with":[26,39],"generalized":[28],"pruritic":[29],"rash,":[30],"joint":[31],"pains,":[32],"and":[33],"fever.":[34],"improved":[36],"upon":[37],"systemic":[40],"steroids.":[41],"SSLR":[42,58],"is":[43,52],"well-described":[44],"to":[45,59],"cefaclor,":[46],"cephalosporin.":[49],"However,":[50],"there":[51],"paucity":[54],"reports":[56],"other":[60],"cephalosporins":[61],"such":[62],"this":[64],"case.":[65]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4659586","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":3}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
